Case Report
Published on 18 Jan 2022
Epstein–Barr Virus-Positive Langerhans Cell Sarcoma: Is There a Link? A Case Report
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.769310
- 3,718 views
- 5 citations
Type at least 3 characters
2,070 articles
articles
Original Research
Published on 18 Jan 2022
Comparable Outcomes and Health-Related Quality of Life for Severe Aplastic Anemia: Haploidentical Combined With a Single Cord Blood Unit vs Matched Related Transplants
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.714033
- 4,239 views
- 9 citations
Editorial
Published on 17 Jan 2022
Editorial: New Insights Into the Complexity of Tumor Immunology in B-Cell Malignancies: Prognostic and Predictive Biomarkers and Therapy
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.841763
- 1,900 views
Original Research
Published on 17 Jan 2022
Identification of U937JAK3-M511I Acute Myeloid Leukemia Cells as a Sensitive Model to JAK3 Inhibitor
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.807200
- 6,043 views
- 5 citations
Original Research
Published on 17 Jan 2022
Mutations in JAK/STAT and NOTCH1 Genes Are Enriched in Post-Transplant Lymphoproliferative Disorders
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.790481
- 5,954 views
- 14 citations
Perspective
Published on 14 Jan 2022
Tumor Reduction in Multiple Myeloma: New Concepts for New Therapeutics
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.800309
- 4,512 views
- 2 citations
Original Research
Published on 14 Jan 2022
A Predictor Combining Clinical and Genetic Factors for AML1-ETO Leukemia Patients
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.783114
- 5,809 views
- 9 citations
Mini Review
Published on 13 Jan 2022
“Double-Hit” Chronic Lymphocytic Leukemia, Involving the TP53 and MYC Genes
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.826245
- 4,969 views
- 8 citations
Review
Published on 13 Jan 2022
Progress in the Treatment of HIV-Associated Lymphoma When Combined With the Antiretroviral Therapies
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.798008
- 9,088 views
- 36 citations
Original Research
Published on 13 Jan 2022
Post-hoc Analysis of Pharmacodynamics and Single-Agent Activity of CD3xCD123 Bispecific Antibody APVO436 in Relapsed/Refractory AML and MDS Resistant to HMA or Venetoclax Plus HMA
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.806243
- 5,063 views
- 5 citations
Systematic Review
Published on 12 Jan 2022
Efficacy and Safety of Autologous Stem-Cell Transplantation as Part of First-Line Treatment for Newly Diagnosed Primary Central Nervous System Lymphoma: A Systematic Review and Meta-Analysis
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.799721
- 5,557 views
- 10 citations
Case Report
Published on 12 Jan 2022
Successful Imatinib Treatment for Systemic Mastocytosis Associated With Myelodysplastic/Myeloproliferative Neoplasm: Report of a Case and Literature Review
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.819097
- 4,279 views
- 4 citations
Review
Published on 11 Jan 2022
Determinants of Drug Resistance in B-Cell Non-Hodgkin Lymphomas: The Case of Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.801124
- 4,825 views
- 2 citations
Original Research
Published on 11 Jan 2022
Impact of Epstein-Barr Virus on Peripheral T-Cell Lymphoma Not Otherwise Specified and Angioimmunoblastic T-Cell Lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.797028
- 6,614 views
- 20 citations
Brief Research Report
Published on 10 Jan 2022
Personally Tailored Survival Prediction of Patients With Follicular Lymphoma Using Machine Learning Transcriptome-Based Models
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.705010
- 5,133 views
- 10 citations
Review
Published on 10 Jan 2022
CARving the Path to Allogeneic CAR T Cell Therapy in Acute Myeloid Leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.800110
- 10,385 views
- 12 citations
Mini Review
Published on 06 Jan 2022
Hypomethylating Agent-Based Combination Therapies to Treat Post-Hematopoietic Stem Cell Transplant Relapse of Acute Myeloid Leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.810387
- 8,251 views
- 19 citations
Original Research
Published on 06 Jan 2022
Notch2 Increases the Resistance to Venetoclax-Induced Apoptosis in Chronic Lymphocytic Leukemia B Cells by Inducing Mcl-1
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.777587
- 5,478 views
- 18 citations
Review
Published on 06 Jan 2022
BMT for Myelodysplastic Syndrome: When and Where and How
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.771614
- 14,883 views
- 15 citations
Original Research
Published on 06 Jan 2022
Preemptive Immunotherapy for Minimal Residual Disease in Patients With t(8;21) Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.773394
- 5,139 views
- 16 citations
Case Report
Published on 05 Jan 2022
Case Report: Large Granular Lymphocyte Leukemia (LGLL)—A Case Series of Challenging Presentations
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.775313
- 7,388 views
- 5 citations
Original Research
Published on 05 Jan 2022
Ex Vivo Chemosensitivity Profiling of Acute Myeloid Leukemia and Its Correlation With Clinical Response and Outcome to Chemotherapy
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.793773
- 4,291 views
- 8 citations
Brief Research Report
Published on 05 Jan 2022
CXCR4 Mediates Enhanced Cell Migration in CALM-AF10 Leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.708915
- 4,422 views
- 4 citations
Original Research
Published on 04 Jan 2022
Integrated Transcriptomic Analysis Reveals a Distinctive Role of YAP1 in Extramedullary Invasion and Therapeutic Sensitivity of Multiple Myeloma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.787814
- 6,518 views
- 8 citations